Mini-symposium: New precision medicine tools for hormone dependent cancers

April 9th 13.30-15.30, Medicon Village, Allvar lecture hall

Coffee and fika will be served

• Gene expression classifiers for tailored breast cancer radiotherapy

• Novel liquid biopsy technology for advanced prostate cancer

• Multimodal AI treatment response prediction for prostate and other cancers

Speakers:

Dr. Laura Chang, PhD, Vice President, Artera AI, San Francisco, CA, USA

Dr. Shuang G. Zhao, MD, Assistant Professor and co-director of the liquid biopsy core

University of Wisconsin, Madison, WI, USA

Host:

Martin Sjöström, MD, PhD, LUCC